Lipid nanoparticles (LNPs) have emerged across the pharmaceutical industry as promising
vehicles to deliver a variety of therapeutics. Currently in the spotlight as vital components of …

Proteolysis targeting chimeras (PROTACs) technology is a novel and promising therapeutic
strategy using small molecules to induce ubiquitin-dependent degradation of proteins. It has …

Abstract PROteolysis TArgeting Chimeras (PROTACs) technology is a new protein-
degradation strategy that has emerged in recent years. It uses bifunctional small molecules …

Phagocytes are key cellular participants determining important aspects of host exposure to
nanomaterials, initiating clearance, biodistribution and the tenuous balance between host …

Sol–gel chemistry offers a flexible approach to obtaining a diverse range of materials. It
allows differing chemistries to be achieved as well as offering the ability to produce a wide …

In this study, we introduced a targeting polymer poly (ethylene glycol)–folic acid (PEG–FA)
on the surface of polydopamine (PDA)-modified mesoporous silica nanoparticles (MSNs) to …

Biomimetic approach offers numerous opportunities to design therapeutic platforms with
enhanced antitumor performance and biocompatibility. Herein we report red blood cell …

Abstract Cluster of differentiation-44 (CD44) is a ubiquitously present glycoprotein on the
surface of mammalian cells that plays a significant role in a number of biological functions …

Nanoparticles as drug delivery system have received much attention in recent years,
especially for cancer treatment. In addition to improving the pharmacokinetics of the loaded …

Polymeric materials have been used in a range of pharmaceutical and biotechnology
products for more than 40 years. These materials have evolved from their earlier use as …